logo

ALGS’s Stock Dilemma: Aligos Therapeutics Inc’s Market Performance and Outlook

ELVT Stock

In terms of market performance, Aligos Therapeutics Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $1.38 on 05/04/23, while the lowest value was $0.54 on 10/24/23.

52-week price history of ALGS Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Aligos Therapeutics Inc’s current trading price is -29.06% away from its 52-week high, while its distance from the 52-week low is 81.70%. The stock’s price range during this period has fluctuated between $0.54 and $1.38. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 0.65 million for the day, which was evidently higher than the average daily volume of 0.41 million over the last three months.

Financial Performance and Market Capitalization

Aligos Therapeutics Inc (ALGS) has experienced a quarterly rise of 32.66% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 74.08M and boasts a workforce of 66 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.7436, with a change in price of +0.2290. Similarly, Aligos Therapeutics Inc recorded 364,997 in trading volume during the last 100 days, posting a change of +30.53%.

ALGS Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ALGS stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.09.

ALGS Stock Stochastic Average

The raw stochastic average for Aligos Therapeutics Inc over the last 50 days is presently at 61.90%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 47.51%. Further, the company’s Stochastic %K and %D values for the last 20 days were 47.56% and 47.22%, respectively.

ALGS Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 47.44%.However, over the last six months, we can see a weaker performance of 34.11%. Over the last 30 days, the price of ALGS has fallen by 3.05%. And in the last five days, it has surged by 2.73%.